Literature DB >> 17786586

Overproduction of mouse estrogen receptor alpha-ligand binding domain decreases bacterial growth.

Swati Ghosh1, Mahendra Kumar Thakur.   

Abstract

Escherichia coli (E. coli) is the most widely used prokaryotic host system for the synthesis of recombinant proteins. The overproduction of recombinant proteins is sometimes lethal to the host cells. In the present study, we expressed the ligand binding domain (LBD) of mouse estrogen receptor alpha (mouse ERalpha) using an expression vector (pIVEX) in E. coli BL21(DE3) and examined the effect of production of this protein on bacterial growth. The expressed protein was immunologically detected as a 30 kD histidine-tagged protein in the soluble part of the bacterial lysate. The overproduction of mouse ERalpha-LBD, as reflected by total protein content and expression pattern, resulted in the decrease of bacterial growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786586     DOI: 10.1007/s11033-007-9128-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

Review 1.  Proteomics: applications in basic and applied biology.

Authors:  N L Anderson; A D Matheson; S Steiner
Journal:  Curr Opin Biotechnol       Date:  2000-08       Impact factor: 9.740

2.  Release of periplasmic enzymes and other physiological effects of beta-lactamase overproduction in Escherichia coli.

Authors:  G Georgiou; M L Shuler; D B Wilson
Journal:  Biotechnol Bioeng       Date:  1988-09-05       Impact factor: 4.530

3.  Patterns of protein synthesis in E. coli: a catalog of the amount of 140 individual proteins at different growth rates.

Authors:  S Pedersen; P L Bloch; S Reeh; F C Neidhardt
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

4.  Functional domains of the human estrogen receptor.

Authors:  V Kumar; S Green; G Stack; M Berry; J R Jin; P Chambon
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Costs of accuracy determined by a maximal growth rate constraint.

Authors:  M Ehrenberg; C G Kurland
Journal:  Q Rev Biophys       Date:  1984-02       Impact factor: 5.318

7.  Chloramphenicol-induced changes in the synthesis of ribosomal, transfer, and messenger ribonucleic acids in Escherichia coli B/r.

Authors:  V Shen; H Bremer
Journal:  J Bacteriol       Date:  1977-06       Impact factor: 3.490

8.  Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria.

Authors:  W E Bentley; N Mirjalili; D C Andersen; R H Davis; D S Kompala
Journal:  Biotechnol Bioeng       Date:  1990-03-25       Impact factor: 4.530

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Gratuitous overexpression of genes in Escherichia coli leads to growth inhibition and ribosome destruction.

Authors:  H Dong; L Nilsson; C G Kurland
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

View more
  3 in total

1.  Overexpression of mouse estrogen receptor-β decreases but its transactivation and ligand binding domains increase the growth characteristics of E. coli.

Authors:  Vijay Paramanik; M K Thakur
Journal:  Mol Biotechnol       Date:  2011-01       Impact factor: 2.695

2.  GST-tagged mouse estrogen receptor alpha-transactivation domain fusion protein is specifically degraded during its over-expression in E. coli and purification.

Authors:  M K Thakur; Swati Ghosh
Journal:  Mol Biol Rep       Date:  2009-03-25       Impact factor: 2.316

3.  Characterization of DNA polymerase β from Danio rerio by overexpression in E. coli using the in vivo/in vitro compatible pIVEX plasmid.

Authors:  Tomomi Ishido; Naoshi Yamazaki; Mitsuru Ishikawa; Ken Hirano
Journal:  Microb Cell Fact       Date:  2011-10-21       Impact factor: 5.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.